Statistics
Publications
4
Citations
172
H-Index
4
Active since
2002
Affiliations
Pfizer (United States)(Current)
Vijayalakshmi Natarajan is an author at Pfizer (United States) specializing in drug discovery, drug development, and medicine.
Publications per year
2002–2023
4
4
Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13
Mark C. Noe, Vijayalakshmi Natarajan, Sheri L. Snow et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 44 citations · Full text
Medicinal Chemistry, Medicine, 3,3-Dimethyl-5-hydroxypipecolic Hydroxamate-based Inhibitors +4
Mark C. Noe, Vijayalakshmi Natarajan, Sheri L. Snow et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 37 citations · Full text
Medicinal Chemistry, 3-Oh-3-methylpipecolic Hydroxamates, Pharmaceutical Science +10
1–4 of 4